Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,820.00
+11.00 (0.39%)
Oct 1, 2026, 3:30 PM JST
Rohto Pharmaceutical Market Cap
Rohto Pharmaceutical has a market cap or net worth of 634.73 billion as of September 30, 2026. Its market cap has increased by 12.97% in one year.
Market Cap
634.73B
Enterprise Value
627.03B
Revenue
353.39B
Ranking
n/a
PE Ratio
19.99
Stock Price
2,820.00
ChartMarket Cap Chart
Since July 4, 1997, Rohto Pharmaceutical's market cap has increased from 64.95B to 634.73B, an increase of 877.32%. That is a compound annual growth rate of 8.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 637.22B | 7.31% |
| Dec 30, 2025 | 593.83B | -9.54% |
| Dec 30, 2024 | 656.47B | 1.21% |
| Dec 29, 2023 | 648.60B | 22.54% |
| Dec 30, 2022 | 529.28B | 33.52% |
| Dec 30, 2021 | 396.39B | 13.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kao Corporation | 3.17T |
| Unicharm | 1.61T |
| Shiseido Company | 1.39T |
| Kobayashi Pharmaceutical | 509.15B |
| Lion Corporation | 480.63B |
| MTG Co., Ltd. | 327.60B |
| KOSE Holdings | 312.92B |
| Pola Orbis Holdings | 301.39B |